Maplight Therapeutics (MPLT): Director filed to sell ~$116K
ROBERT MALENKA, Director at Maplight Therapeutics, filed to sell ~$116K of Maplight Therapeutics shares.
- ~$116K
- planned to sell · 15K shares, around Oct 15, 2026
- Planned for
- Oct 15, 2026
- Notice filed
- Oct 15, 2026
What stands out in this filing
- The planned sale is 0.03% of the company's shares outstanding, as stated on the notice.
- How the shares were acquired, per the notice: Restricted Stock Units.
- The notice says the shares were received as pay (stock awards or options).
- Broker named on the notice: Morgan Stanley Smith Barney LLC Executive Financial Services.
- A Form 144 announces a sale; the Form 4 that follows shows whether it took place, at what price.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 14, 2026Insider10% owner purchased ~$50.1M of MPLT shares in the open market
- Sep 16, 2026InsiderOfficer sold ~$193K of MPLT shares in the open market
- Oct 15, 2026Insider · 6 peopleInsiders: 6 sales (~$1.1M)
What came next
- Nov 16, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 16, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Nov 16, 20265% stakeForbion Growth Opportunities Fund III Cooperatief U.A. reported a passive stake (13G) of 8.4%
- Nov 16, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 1.7%
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Maplight Therapeutics
For Maplight Therapeutics, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MPLT page.
How this filing works
Explore the data
Common questions
Which Maplight Therapeutics (MPLT) insider traded, and how much?
ROBERT MALENKA, Director at Maplight Therapeutics, filed to sell ~$116K of Maplight Therapeutics shares. 15K shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Oct 15, 2026. Notice filed: Oct 15, 2026.
What stands out in this filing?
The planned sale is 0.03% of the company's shares outstanding, as stated on the notice. How the shares were acquired, per the notice: Restricted Stock Units. The notice says the shares were received as pay (stock awards or options).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Maplight Therapeutics recently?
For Maplight Therapeutics, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MPLT page.
Does this mean MPLT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Maplight Therapeutics
- SEC Schedule 13GNov 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
Everything OQRO holds on this company is on its MPLT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
